43rd EBMT UK NAP annual meeting
Friday 21st September 2016, Southampton
Southampton, home to ‘the Saints’, Caribbean cruise liners and birthplace of Craig David, was the venue for our 43rd EBMT UK NAP meeting.
After reluctantly closing registrations at this, our first ever ‘sell out’ meeting, we were keen to ensure that all those who did get a seat were not disappointed. With a fantastically varied programme, a number of top speakers and our EBMT travel grant award winners, there was a great sense of anticipation.
The meeting highlights were many but of particular interest was our one-sided debate ‘Auto vs Allo in Myeloma’. Unfortunately, our Allograft speaker was unable to join us at short notice, but Dr Rachel Hall (Royal Bournemouth County Hospital) delivered a very convincing talk in support of the humble Autograft underlining her argument with some very poignant cases.
Dr Jacqui Stringer, head of complementary therapies and tissue viability at the Christie, Manchester gave us a wonderful insight into her approach to skin GvHD. There was much scribbling in the room as we tried to capture some of her ‘tricks’ and felt very much in awe of the incredible results she demonstrated throughout her presentation.
The room fell silent as we were transfixed by committee member, Suzanne Allman’s (University Hospitals Bristol) whistle stop tour through ‘Schwartz Rounds’ complete with videos to perfectly highlight how these multidisciplinary groups of reflection and support empower us all to have a greater understanding of those around us.
Our travel grant award winners Nicole Gimberiene and Sarah Ware presented their work before lunch. One of our grant winners, Sarah, who had submitted her abstract while on 12 month secondment to cover maternity leave, ended up winning the best Oral Abstract award in Valencia 2016. Good luck to all those who have submitted abstracts for Marseilles!
After a superb lunch and a wander round our charity and pharmaceutical stands we gathered again, this time to listen to Dr Reuben Benjamin (King’s College Hospital, London) and his presentation ‘CarT cells: Licensed to kill!’ The room was still as we took in the details of this ground breaking treatment. There is more to come and he will be presenting further work in this area at EBMT 2017, Marseilles.
Aileen Nield (Sheffield University Hospital) stepped into the breach to take us through the ‘interpretation of the Full Blood Count’. Always a popular session at EBMT and Aileen certainly did not disappoint.
Finally, Nikki McKeag (University Hospital Southampton) provided us with everything you need to know about ‘organ toxicity and late effects’. Leaving nothing out, her comprehensive session was illuminating – there really is always more to learn.
On behalf of the committee, I’d like to thank our sponsors, speakers and all those who attended.
Next year we are planning a combined meeting in Manchester with the EBMT International Study Day. Keep an eye on our website (ebmt.co.uk) for details, to access the presentations from our meeting or to find out more about our group.